ESMO 2024 Insights: Rucaparib +/- Nivo as Maintenance in Newly Diagnosed Ovarian Cancer - ATHENA-COMBO Ph3 Trial

153 views
September 19, 2024
0 Comments
Login to view comments. Click here to Login